Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Occupation and risk of meningioma and acoustic neuroma in the United States.

Rajaraman P, De Roos AJ, Stewart PA, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Am J Ind Med. 2004 May;45(5):395-407.

PMID:
15095422
2.

Facilitative mechanisms of lead as a carcinogen.

Silbergeld EK.

Mutat Res. 2003 Dec 10;533(1-2):121-33. Review.

PMID:
14643416
3.

Lead, chemical porphyria, and heme as a biological mediator.

Fujita H, Nishitani C, Ogawa K.

Tohoku J Exp Med. 2002 Feb;196(2):53-64.

4.

Epidemiology of primary brain tumors: current concepts and review of the literature.

Wrensch M, Minn Y, Chew T, Bondy M, Berger MS.

Neuro Oncol. 2002 Oct;4(4):278-99. Review.

5.

Occupation, exposure to chemicals and risk of gliomas and meningiomas in Sweden.

Navas-Acién A, Pollán M, Gustavsson P, Plato N.

Am J Ind Med. 2002 Sep;42(3):214-27.

PMID:
12210690
6.

Delta-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review.

Kelada SN, Shelton E, Kaufmann RB, Khoury MJ.

Am J Epidemiol. 2001 Jul 1;154(1):1-13. Review.

PMID:
11427399
7.

Delta-aminolevulinate dehydratase polymorphism and blood lead levels in Chinese children.

Shen XM, Wu SH, Yan CH, Zhao W, Ao LM, Zhang YW, He JM, Ying JM, Li RQ, Wu SM, Guo D.

Environ Res. 2001 Mar;85(3):185-90.

PMID:
11237505
8.

Cellular-telephone use and brain tumors.

Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine HA, Black PM, Loeffler JS, Linet MS.

N Engl J Med. 2001 Jan 11;344(2):79-86.

9.

Lead and cancer in humans: where are we now?

Steenland K, Boffetta P.

Am J Ind Med. 2000 Sep;38(3):295-9. Review.

PMID:
10940967
10.

Association between aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan.

Hsieh LL, Liou SH, Chen YH, Tsai LC, Yang T, Wu TN.

J Occup Environ Med. 2000 Feb;42(2):151-5.

PMID:
10693075
11.

Risk factors for meningioma in adults: a case-control study in northeast China.

Hu J, Little J, Xu T, Zhao X, Guo L, Jia X, Huang G, Bi D, Liu R.

Int J Cancer. 1999 Oct 29;83(3):299-304.

12.

Occupational risk factors for cancer of the central nervous system (CNS) among US women.

Cocco P, Heineman EF, Dosemeci M.

Am J Ind Med. 1999 Jul;36(1):70-4.

PMID:
10361589
13.

Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers.

Fleming DE, Chettle DR, Wetmur JG, Desnick RJ, Robin JP, Boulay D, Richard NS, Gordon CL, Webber CE.

Environ Res. 1998 Apr;77(1):49-61.

PMID:
9593628
14.

Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers.

Alexander BH, Checkoway H, Costa-Mallen P, Faustman EM, Woods JS, Kelsey KT, van Netten C, Costa LG.

Environ Health Perspect. 1998 Apr;106(4):213-6.

15.

Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes.

Bergdahl IA, Grubb A, Schütz A, Desnick RJ, Wetmur JG, Sassa S, Skerfving S.

Pharmacol Toxicol. 1997 Oct;81(4):153-8.

PMID:
9353844
16.

CYP2D6 multiallelism.

Daly AK, Steen VM, Fairbrother KS, Idle JR.

Methods Enzymol. 1996;272:199-210. No abstract available.

PMID:
8791778
17.

delta-Aminolevulinate dehydrase: a new genetic polymorphism in man.

Battistuzzi G, Petrucci R, Silvagni L, Urbani FR, Caiola S.

Ann Hum Genet. 1981 Jul;45(Pt 3):223-9.

PMID:
7305279
18.

Polymorphism of delta-aminolevulinic acid dehydratase in lead-exposed workers.

Ziemsen B, Angerer J, Lehnert G, Benkmann HG, Goedde HW.

Int Arch Occup Environ Health. 1986;58(3):245-7. No abstract available.

PMID:
3770964
19.

Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42.

[No authors listed]

IARC Monogr Eval Carcinog Risks Hum Suppl. 1987;7:1-440. No abstract available.

PMID:
3482203

Supplemental Content

Support Center